Management of blood glucose in type 2 diabetes mellitus.
about
Role of apolipoprotein E in neurodegenerative diseasesTherapeutic phytogenic compounds for obesity and diabetesAge and the metabolic syndrome as risk factors for ischemic stroke: improving preclinical models of ischemic strokeThe efficacy of dapagliflozin combined with hypoglycemic drugs in treating type 2 diabetes: protocol for meta-analysis of randomized controlled trials.Perceptions of physical activity and motivational interviewing among rural African-American women with type 2 diabetesKCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.Metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus.Diabetes diagnosis and exercise initiation among older Americans.Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention.Improved A1C and Lipid Profile in Patients Referred to Diabetes Education Programs in a Wide Health Care Network: A Retrospective Study.The Murphy Roths Large (MRL) mouse strain is naturally resistant to high fat diet-induced hyperglycemiaAssociation of rs7903146 (IVS3C/T) and rs290487 (IVS3C/T) polymorphisms in TCF7L2 with type 2 diabetes in 9,619 Han Chinese populationThe efficacy of dapagliflozin combined with hypoglycaemic drugs in treating type 2 diabetes mellitus: meta-analysis of randomised controlled trials.Identifying module biomarker in type 2 diabetes mellitus by discriminative area of functional activity.Comparative functional exercise capacity of patients with type 2-diabetes and healthy controls: a case control studyGlycemic control rate of T2DM outpatients in China: a multi-center survey.Self-Reported Periodontitis and Incident Type 2 Diabetes among Male Workers from a 5-Year Follow-Up to MY Health Up Study.Type 2 diabetes mellitus: a review of current trendsPharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine.An opportunistic pre-diabetes screening program offered with existing hypertension screening.Design of Potent and Highly Selective Inhibitors for Human β-Secretase 2 (Memapsin 1), a Target for Type 2 Diabetes.High glucose activates the alternative ACE2/Ang-(1-7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β-cells.Genetic variants of nuclear factor erythroid-derived 2-like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast ChinaManagement of the metabolic syndrome and type 2 diabetes through lifestyle modification.The effects of gliclazide, metformin, and acarbose on body composition in patients with newly diagnosed type 2 diabetes mellitus.Cellular Signaling Pathways in Insulin Resistance-Systems Biology Analyses of Microarray Dataset Reveals New Drug Target Gene Signatures of Type 2 Diabetes Mellitus.Insulinization: A promising strategy for the treatment of type 2 diabetes mellitus.Modulation of CYP3a expression and activity in mice models of type 1 and type 2 diabetes.Sociodemographic variables for predicting diabetes in Panama.Increased Micronuclei Frequency in Oral and Lingual Epithelium of Treated Diabetes Mellitus Patients.Investigation of β-Sitosterol and Prangol Extracted from Achillea Tenoifolia Along with Whole Root Extract on Isolated Rat Pancreatic Islets.Noninvasive Glucose Monitoring with a Contact Lens and SmartphoneThe Effect of L. Fruit Juice on the Blood Sugar Level and Other Serum Parameters in Patients with Diabetes Type 2
P2860
Q26799413-B937F682-E69B-4145-A0B3-D96F2D90DCDBQ27004043-922C98D1-3EA3-4B7A-95C9-E9C81A0C5D95Q28391839-515426C4-9790-4A8C-A5B7-73019A01FF7AQ30557454-2121E1E6-73A6-4E91-84BE-0D851A7CDC11Q33677270-45187812-B4D2-4506-B1CC-BA10CC0FA7D4Q33771570-3A285453-A6B1-488D-870E-0C24A4A92550Q33854354-7285A741-0B55-41A2-B92F-11F8CA089464Q33929438-45BA0EAE-D9D0-485F-90C9-BD908F2BD3D1Q34201551-844BFC1C-31F4-454E-A3D0-BDF76F2D859CQ34510900-788C46B7-8BE6-4F1E-A1E3-C54D22145311Q34614691-3794E0B8-3A91-4376-B38B-8AC370E9B73BQ34639551-243B5BDF-27AE-4766-9CBB-B102823E6333Q35141884-6510FE29-D4B5-4E3B-99EA-A640A7774AF9Q35218961-D422EBF2-32A1-42EA-899A-524B11D2524FQ35241287-64255A27-DDAA-4FC4-A004-7B016B834317Q35663876-19ADDBD2-9806-42B6-A4CB-AA51B1252ABAQ35999499-1BC8A16E-B6B6-4048-A53A-4A5303C67599Q36299039-6E61E1AF-3290-46DE-B341-39D0259792A2Q36441465-7217EE78-DAF4-4A14-A2D6-3BDE60560C2EQ36478482-9C4240E0-26D2-4C0E-82FF-6032B6FC5CA6Q37028575-0F35C3E8-0F80-433D-9945-065B8BBF7373Q37265803-29CC9CE0-7563-4520-B5A5-A67ABC65EA1BQ37370799-9F81A50E-261D-4D32-B08B-0A47C666C0BAQ37463193-0AA48904-D32C-4890-814C-028E36566ADAQ37502106-15D4E15C-9605-481E-9E93-F2D64348AC20Q37604341-01B01D0A-3BE0-49CB-A109-05E6015A458DQ41860557-A8070CF5-B882-4F40-ABB2-63071B9ED15EQ42145594-A942844C-E0E9-4213-BC0A-40394481FE59Q43087608-DE9207B3-6421-43A7-BD60-A6EEF61B8E77Q54943067-5847BA8F-8BB3-4C2E-972E-0AFDF4B37794Q55378960-B9173DF5-6D93-4634-9872-86A873ACC3D8Q58702096-4A5DFAF0-5E46-4118-AE87-7B3B8591BBFEQ58798692-C5EF39F7-7ED0-41AF-B67D-D5571CD9BAFB
P2860
Management of blood glucose in type 2 diabetes mellitus.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Management of blood glucose in type 2 diabetes mellitus.
@ast
Management of blood glucose in type 2 diabetes mellitus.
@en
Management of blood glucose in type 2 diabetes mellitus.
@nl
type
label
Management of blood glucose in type 2 diabetes mellitus.
@ast
Management of blood glucose in type 2 diabetes mellitus.
@en
Management of blood glucose in type 2 diabetes mellitus.
@nl
prefLabel
Management of blood glucose in type 2 diabetes mellitus.
@ast
Management of blood glucose in type 2 diabetes mellitus.
@en
Management of blood glucose in type 2 diabetes mellitus.
@nl
P2093
P1476
Management of blood glucose in type 2 diabetes mellitus
@en
P2093
Cynthia M Ripsin
Helen Kang
Randall J Urban
P577
2009-01-01T00:00:00Z